Wojcicki: How 23andMe Disrupts Health Care With DNA

Nov. 26 (Bloomberg) -- Anne Wojcicki, CEO & co-founder at 23andMe, discusses the company’s battle with the FDA over their $99 DNA testing product and the company’s plans for growth using big data. She speaks on Bloomberg Television’s “Market Makers.”
TPP Trade: Is It a Good Deal for the U.S.?
55:11 - U.S. Trade Representative Michael Froman weighs in on the proposed Trans-Pacific Partnership trade deal. He speaks on "Bloomberg Markets." (Source: Bloomberg)
  • Nasdaq Off Its Session Lows
  • Euro Market Movers: SABMiller, Volkswagen, Tesco
  • Tesla Downgraded, Stock Drops